.png)
The Scalpel's Edge
The Scalpel's Edge is a podcast hosted by Dr. Tim Sayed, a leading plastic surgeon and physician innovator, dedicated to exploring the forefront of excellence and wellness. The show delves into cutting-edge medical technologies, industry controversies, and innovative approaches to healthcare and personal growth. With insightful discussions featuring top leaders and innovators from healthcare and beyond, the podcast aims to optimize performance, enhance wellness, and deepen self-understanding. Listeners can follow the podcast on platforms like Apple and Spotify to join this journey into groundbreaking advancements and out-of-the-box thinking.
The Scalpel's Edge
Ep. 15 - GLP1 Breakthroughs and Real Results
In this episode of The Scalpel’s Edge, Dr. Tim Sayed breaks down compelling new research on GLP1 medications like semaglutide, tirzepatide, and the latest entrant, ecnoglutide. With real-world data from Cleveland Clinic and insights from an international Phase 3 trial, Dr. Sayed explores how these medications are performing outside of clinical trials, what happens after patients stop taking them, and why cost, side effects, and genetic profiles may impact their effectiveness.
As a board-certified plastic surgeon who has personally used these medications, Dr. Sayed shares clinical insight, practical considerations, and where innovation in weight loss treatment is headed next. If you're curious about the future of GLP1s, their metabolic benefits, and what it means for real patients, this one’s for you.
Contact Dr. Tim Sayed:
Phone: (858) 247-2933
Email: info@timsayedmd.com
Website: timsayedmd.com
Instagram: @timsayedmd
YouTube: @Timsayedmd
Facebook: Tim Sayed MD